Your session is about to expire
← Back to Search
Prehabilitation for Esophageal Cancer
N/A
Waitlist Available
Led By Enrico M Minnella, MD PhD
Research Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients with non-metastatic esophageal cancer undergoing neo-adjuvant chemotherapy and surgery.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to post neo-adjuvant therapy (average duration 6-8 weeks)
Awards & highlights
Study Summary
This trial will test if prehabilitation, which is preparing for surgery beforehand, can help people with esophageal cancer.
Eligible Conditions
- Esophageal Cancer
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline to post neo-adjuvant therapy (average duration 6-8 weeks)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to post neo-adjuvant therapy (average duration 6-8 weeks)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Oxygen consumption (VO2)
Trial Design
2Treatment groups
Experimental Treatment
Group I: Supervised PrehabilitationExperimental Treatment1 Intervention
Prehabilitation will include exercise, nutrition, and anxiety-coping intervention.
This group will receive a supervised, in-hospital training.
Group II: Home-based PrehabilitationExperimental Treatment1 Intervention
Prehabilitation will include exercise, nutrition, and anxiety-coping intervention.
This group will receive a home-based training.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Prehabilitation
2013
Completed Phase 3
~1040
Find a Location
Who is running the clinical trial?
McGill University Health Centre/Research Institute of the McGill University Health CentreLead Sponsor
442 Previous Clinical Trials
159,120 Total Patients Enrolled
Enrico M Minnella, MD PhDPrincipal InvestigatorMcGill University
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger